Pathway Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,624	Closed	-$1.08M	–	7
2020 Q4	$1.08M	Buy	+1,624	New	+$1.08M	84.38%	1